WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Independent UN experts urge Yemen’s Houthis to free detained Baha'i followers
Jets trade defensive lineman John Franklin
Panthers put more offensive playmakers around young QB Bryce Young in NFL draft
From Catherine Zeta Jones and Carys Douglas to Cindy Crawford and Kaia Gerber
Brazil replaces injured goalkeeper Ederson in Copa America squad
Chiefs owner: Leaving Arrowhead is an option after rejected sales tax
PSG fails to win the French league after drawing with struggling Le Havre
The Bears see bigger things in store after drafting QB Caleb Williams, WR Rome Odunze
Travis Kelce downs whiskey shot on slice of bread at Kelce Jam without Taylor Swift
Benintendi hits 2nd home of game in 10th, White Sox beat Rays 8
Kate Hudson hits the stage to debut songs from her new album Glorious at star
Chinese scientists propose new solutions for fast